Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of entrectinib in patients with NTRK or ROS1 fusion-positive NSCLC with CNS metastases at baseline
    Meeting Abstract

    Dziadziuszko, R.; Siena, S.; Tan, D. S. W.; Cho, B. C.; Ahn, M. J.; Goto, K.; Garrido-Lopez, P.; Farago, A. F.; Loong, H. H. F.; Tosi, D.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer
    Meeting Abstract

    Drilon, A.; Moreno, V.; Patel, J.; Lassen, U. N.; Solomon, B.; Rosen, L.; Leyvraz, S.; Tan, D. S. W.; Reeves, J. A.; Dima, L.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy and safety with selpercatinib by last prior systemic therapy received in patients (Pts) with RET fusion + non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Gautschi, O.; Drilon, A.; Tan, D. S. W.; Oxnard, G. R.; McCoach, C.; Goto, K.; Park, K.; Alonso Casal, G.; de Braud, F.; French, P.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Impact of KRAS mutations and subtypes on efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Mazieres, J.; Tomasini, P.; Lusque, A.; Boucekine, M.; Gautschi, O.; Cortot, A. B.; Couraud, S.; Thai, A.; Ng, T.; Greillier, L.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Tepotinib in patients (pts) with advanced NSCLC with MET exon 14 (METex14) skipping: Overall efficacy results from VISION cohort A
    Meeting Abstract

    Mazieres, J.; Paik, P. K.; Felip, E.; Veillon, R.; Sakai, H.; Cortot, A. B.; Viteri, S.; Garassino, M. C.; Van Meerbeeck, J. P.; Raskin, J.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Activity of tepotinib in brain metastases (BM): Preclinical models and clinical data from patients (pts) with MET exon 14 (METex14) skipping NSCLC
    Meeting Abstract

    Viteri, S.; Mazieres, J.; Veillon, R.; Felip, E.; Le, X.; Garassino, M. C.; Stanton, T. S.; Morise, M.; Lee, J. S.; Matsumoto, S.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib)
    Meeting Abstract

    Hong, D. S.; Bang, Y. J.; Barlesi, F.; Durm, G. A.; Falchook, G. S.; Govindan, R.; Dy, G. K.; Park, K.; Strickler, J. H.; Burns, T. F.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Updated results from a phase I/II study of mobocertinib (TAK788) in NSCLC with EGFR exon 20 insertions (exon20ins)
    Meeting Abstract

    Riely, G. J.; Neal, J. W.; Camidge, D. R.; Spira, A.; Piotrowska, Z.; Horn, L.; Costa, D. B.; Tsao, A.; Patel, J.; Gadgeel, S.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • MEDI1191, a novel IL-12 mRNA therapy for intratumoral (IT) injection for advanced solid tumours
    Meeting Abstract

    Marron, T.; Subbiah, V.; Hamid, O.; Goel, S.; Hellmann, M. D.; Carneiro, B. A.; Pate, S. P.; de Vries, E.; Luheshi, N.; Hamid, O.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • ON-TRK: A non-interventional study of larotrectinib in patients with TRK fusion cancer
    Meeting Abstract

    Leyvraz, S.; Yang, J. C. H.; Casali, P. G.; Castro, G.; Kim, E. S.; Lassen, U. N.; Lopez-Rios, F.; Penault-Llorca, F.; Pappo, A.; Rudzinski, E. R.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save